⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for etrolizumab

Every month we try and update this database with for etrolizumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsNCT02136069
Ulcerative Coli...
Etrolizumab
Infliximab
Placebo (IV)
Placebo (Inject...
18 Years - 80 YearsHoffmann-La Roche
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsNCT02163759
Ulcerative Coli...
Adalimumab
Adalimumab Plac...
Etrolizumab
Etrolizumab Pla...
18 Years - 80 YearsHoffmann-La Roche
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsNCT02136069
Ulcerative Coli...
Etrolizumab
Infliximab
Placebo (IV)
Placebo (Inject...
18 Years - 80 YearsHoffmann-La Roche
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsNCT02171429
Ulcerative Coli...
Adalimumab
Adalimumab Plac...
Etrolizumab
Etrolizumab Pla...
18 Years - 80 YearsHoffmann-La Roche
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsNCT02171429
Ulcerative Coli...
Adalimumab
Adalimumab Plac...
Etrolizumab
Etrolizumab Pla...
18 Years - 80 YearsHoffmann-La Roche
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) InhibitorsNCT02165215
Colitis, Ulcera...
Etrolizumab
Placebo
18 Years - 80 YearsHoffmann-La Roche
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsNCT02163759
Ulcerative Coli...
Adalimumab
Adalimumab Plac...
Etrolizumab
Etrolizumab Pla...
18 Years - 80 YearsHoffmann-La Roche
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: